1 Section of Paediatrics, Department of Medicine, Imperial College London, London, United Kingdom.
2 MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
Am J Respir Crit Care Med. 2018 May 15;197(10):1265-1274. doi: 10.1164/rccm.201708-1762OC.
Immunophenotypes of antiviral responses, and their relationship with asthma, allergy, and lower respiratory tract infections, are poorly understood.
We characterized multiple cytokine responses of peripheral blood mononuclear cells to rhinovirus stimulation, and their relationship with clinical outcomes.
In a population-based birth cohort, we measured 28 cytokines after stimulation with rhinovirus-16 in 307 children aged 11 years. We used machine learning to identify patterns of cytokine responses, and related these patterns to clinical outcomes, using longitudinal models. We also ascertained phytohemagglutinin-induced T-helper cell type 2 (Th2)-cytokine responses (PHA-Th2).
We identified six clusters of children based on their rhinovirus-16 responses, which were differentiated by the expression of four cytokine/chemokine groups: interferon-related (IFN), proinflammatory (Inflam), Th2-chemokine (Th2-chem), and regulatory (Reg). Clusters differed in their clinical characteristics. Children with an IFNInflamTh2-chemReg rhinovirus-16-induced pattern had a PHA-Th2 response, and a very low asthma risk (odds ratio [OR], 0.08; 95% confidence interval [CI], 0.01-0.81; P = 0.03). Two clusters had a high risk of asthma and allergic sensitization, but with different trajectories from infancy to adolescence. The IFNInflamTh2-chemReg cluster exhibited a PHA-Th2 response and was associated with early-onset asthma and sensitization, and the highest risk of asthma exacerbations (OR, 1.37; 95% CI, 1.07-1.76; P = 0.014) and lower respiratory tract infection hospitalizations (OR, 2.40; 95% CI, 1.26-4.58; P = 0.008) throughout childhood. In contrast, the IFNInflamTh2-chemReg cluster with a rhinovirus-16-cytokine pattern was characterized by a PHA-Th2 response, and a low prevalence of asthma/sensitization in infancy that increased sharply to become the highest among all clusters by adolescence (but with a low risk of asthma exacerbations).
Early-onset troublesome asthma with early-life sensitization, later-onset milder allergic asthma, and disease protection are each associated with different patterns of rhinovirus-induced immune responses.
抗病毒反应的免疫表型及其与哮喘、过敏和下呼吸道感染的关系尚未完全阐明。
我们描述了外周血单个核细胞对鼻病毒刺激的多种细胞因子反应,并研究了其与临床结局的关系。
在一项基于人群的出生队列中,我们在 307 名 11 岁儿童中测量了 28 种细胞因子,这些儿童在接受鼻病毒-16 刺激后。我们使用机器学习来识别细胞因子反应的模式,并使用纵向模型将这些模式与临床结局相关联。我们还确定了植物血球凝集素诱导的辅助性 T 细胞 2(Th2)-细胞因子反应(PHA-Th2)。
我们根据 307 名儿童对鼻病毒-16 的反应,基于他们的反应确定了六个聚类,这些聚类通过四个细胞因子/趋化因子组的表达来区分:干扰素相关(IFN)、促炎(Inflam)、Th2-趋化因子(Th2-chem)和调节(Reg)。聚类在其临床特征上存在差异。具有 IFNInflamTh2-chemReg 鼻病毒-16 诱导模式的儿童具有 PHA-Th2 反应,且哮喘风险极低(比值比 [OR],0.08;95%置信区间 [CI],0.01-0.81;P=0.03)。两个聚类具有较高的哮喘和过敏致敏风险,但从婴儿期到青春期的轨迹不同。IFNInflamTh2-chemReg 聚类表现出 PHA-Th2 反应,与早发性哮喘和致敏有关,哮喘加重的风险最高(OR,1.37;95%CI,1.07-1.76;P=0.014)和下呼吸道感染住院(OR,2.40;95%CI,1.26-4.58;P=0.008)在整个儿童时期。相比之下,具有 IFNInflamTh2-chemReg 鼻病毒-16 细胞因子模式的 IFNInflamTh2-chemReg 聚类的特征是 PHA-Th2 反应,并且在婴儿期哮喘/致敏的患病率较低,但到青春期时,患病率急剧上升至所有聚类中最高(但哮喘加重的风险较低)。
与哮喘发作相关的早期发病和生活过敏,后期发病的较轻的过敏性哮喘,以及疾病保护,均与不同的鼻病毒诱导免疫反应模式有关。